Sales of existing homes in the US fell for a third straight month in May while prices set another record, underscoring persistent affordability challenges that hobbled the important spring selling season. Contract closings decreased 0.7% from a month earlier to…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Labour is planning to allow renters to bid “voluntarily” above the asking price on properties, in a move experts warn…
Microsoft-backed OpenAI has acquired search and database analytics firm Rockset for an undisclosed sum, the ChatGPT maker said on Friday. A technology Rockset offers called vector search has benefited from increased adoption as more applications use artificial intelligence to power…
Summer is officially here, though you could be forgiven for thinking it started weeks ago with the high temperatures much of the country has been facing. And as another extreme heat wave moves into the Midwest and Northeast, the Centers…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Ten UK train operators have said they are reviewing fare-evasion prosecutions that date back years after a court cast doubt…
Nvidia just formed a bearish technical pattern that is signaling a reversal ahead. The red-hot chipmaker dropped 3.5% on Thursday after it temporarily unseated Microsoft as the most valuable public company in the U.S. Thursday’s decline marked a “bearish engulfing”…
Theranos is the telltale story of when VC funding goes awry. The company, which claimed it developed a revolutionary blood-testing technology, raised roughly $724 million from investors. It was valued at $9 billion before it imploded because of a fatal…
Britain’s next prime minister — barring a flabbergasting reversal — is sitting next to me in Southampton’s Retro Cafe chewing a hash brown as he takes a break from electioneering. Amid the frantic rhythm of the campaign trail, we don’t…
Vials on the Wegovy line at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Friday, March 8, 2024. Bloomberg | Bloomberg | Getty Images LONDON — Shares of Denmark’s Zealand Pharma popped nearly 23% in Friday morning deals,…
Try saying “no” when a child asks for a smartphone. What comes after, parents everywhere can attest, begins with some variation of: “Everyone has one. Why can’t I?” But what if no pre-teen in sight has one — and what…